Status:

UNKNOWN

The Use of Lisdexamfetamine for Children Aged 7-13 With Attention Deficit Disorders

Lead Sponsor:

Aarhus University Hospital

Collaborating Sponsors:

Takeda

Conditions:

Attention Deficit Disorder

Attention Deficit Hyperactivity Disorder

Eligibility:

All Genders

7-13 years

Brief Summary

Aiming at improving clinical practice regarding the use of lisdexamfetamine for the treatment of ADHD in children, the investigators want to retrospectively map the clinical use of lisdexamfetamine at...

Detailed Description

Background Attention deficit hyperactivity disorder (ADHD) is characterised by the core symptoms of inattention, hyperactivity and impulsivity, which are excessive for the person's age and developmen...

Eligibility Criteria

Inclusion

  • Age 7-13 years at referral to the outpatient clinic.
  • Have been diagnosed with one or more of the following ICD-10 diagnoses: F90.0 Disturbance of activity and attention; F90.1 Hyperkinetic conduct disorder; F90.8 Other hyperkinetic disorders; F90.9 Hyperkinetic disorder, unspecified; F98.8 Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence (attention deficit disorder without hyperactivity, excessive masturbation, nail-biting, nose-picking, thumb-sucking), F98.8C Attention deficit disorder without hyperactivity.
  • Manual review of patients with the diagnosis F98.8 is deemed necessary to identify all patients with attention deficit disorder without hyperactivity due to changed diagnostic practice.
  • Prescription of lisdexamfetamine sometime during the period from 1 April 2013 to 5 November 2019.

Exclusion

  • Prescribtion of ADHD medication prior to 1 April 2013.
  • Patients with the diagnosis F98.8 with the following denominations will be excluded; excessive masturbation, nail-biting, nose-picking, thumb-sucking.

Key Trial Info

Start Date :

January 19 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2022

Estimated Enrollment :

413 Patients enrolled

Trial Details

Trial ID

NCT04727476

Start Date

January 19 2021

End Date

May 1 2022

Last Update

August 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Child and Adolescent Psychiatry, Aarhus University Hospital

Aarhus, Region Midt, Denmark, 8200